Newborn screening programs are a collaborative effort between public health departments, hospitals, government agencies and the parents of the children screened. As new technologies evolve, new challenges are faced. The goal of this project is to examine the financial, ethical, legal and social issues posed by the use of tandem mass spectrometry in newborn screening.
